- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma

Pharmaceutical Field says…

It’s now over a month since the Government published its revisions to the Health and Social Care Bill. Those revisions will soon be debated in Parliament as MPs re-evaluate the legislation. Crunch time is fast approaching. And assuming that the wreckage of the phone hacking scandal has been cleared from the nation’s front pages, it’s safe to assume that Andrew Lansley’s apparently radical overhaul of the NHS will yet again face great media scrutiny.

Current commentary suggests that the redrawn plans have created confusion where there was once fleeting clarity. One senior pharma industry leader used Viz-like profanities to describe the shift from focused GP Consortia to broader Clinical Commissioning Groups. Pharma’s key customer-base has been a moving target for many years. Just when it threatened to narrow and become clearer, it moved again. The BMA, who pushed for change, is now seeking assurances that the revisions aren’t simply a case of ‘turning a pig’s breakfast into a dog’s dinner.’

DH attempts to clarify the transition to a new landscape through the creation of SHA clusters – however sensible and necessary – will undoubtedly add to the short-term confusion. For those inside the NHS, and those selling into it.

 

Chris Ross, Editor

The latest issue of Pharmaceutical Field can be found online. iPad and iPhone users can download the free Pf App.

- Advertisement -

MORE FROM AUTHOR

- Advertisement -

LATEST POSTS

Subscribe

Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription